These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 10599727

  • 1. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
    [Abstract] [Full Text] [Related]

  • 2. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [Abstract] [Full Text] [Related]

  • 3. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [Abstract] [Full Text] [Related]

  • 4. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
    [Abstract] [Full Text] [Related]

  • 5. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
    Sas TC, Gerver WJ, de Bruin R, Stijnen T, de Muinck Keizer-Schrama SM, Cole TJ, van Teunenbroek A, Drop SL.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, van Leeuwen WJ, Asarfi A, van Rijn RR, Drop SL, Dutch Advisory Group on Growth Hormone.
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [Abstract] [Full Text] [Related]

  • 7. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome.
    van Pareren YK, Duivenvoorden HJ, Slijper FM, Koot HM, Drop SL, de Muinck Keizer-Schrama SM.
    Horm Res; 2005 Sep; 63(5):238-44. PubMed ID: 15900109
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
    Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [Abstract] [Full Text] [Related]

  • 11. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama SM, Sas TC.
    Acta Paediatr Suppl; 1999 Dec; 88(433):126-9. PubMed ID: 10626563
    [Abstract] [Full Text] [Related]

  • 13. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S, Van den Broeck J, Sas T, Hokken-Koelega A.
    Horm Res; 1999 Dec; 51 Suppl 3():127-31. PubMed ID: 10592457
    [Abstract] [Full Text] [Related]

  • 14. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial.
    Stephure DK, Canadian Growth Hormone Advisory Committee.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3360-6. PubMed ID: 15784709
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Löfström A, Jonsson B, Rosenfeld RG.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [Abstract] [Full Text] [Related]

  • 16. Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood.
    Kriström B, Ankarberg-Lindgren C, Barrenäs ML, Nilsson KO, Albertsson-Wikland K.
    Front Endocrinol (Lausanne); 2023 Aug; 14():1197897. PubMed ID: 37529614
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [Abstract] [Full Text] [Related]

  • 18. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 19. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
    Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T, Root AW.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
    [Abstract] [Full Text] [Related]

  • 20. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.